Psychedelic Therapy vs Antidepressants for the Treatment of Depression Under Equal Unblinding Conditions
18/03/2026 | 22 min
Interview with Balázs Szigeti, PhD, author of Psychedelic Therapy vs Antidepressants for the Treatment of Depression Under Equal Unblinding Conditions: A Systematic Review and Meta-Analysis. Hosted by John Torous, MD.
Related Content: Psychedelic Therapy vs Antidepressants for the Treatment of Depression Under Equal Unblinding Conditions
Once-Weekly Semaglutide in Adults With Alcohol Use Disorder
25/02/2026 | 19 min
Interview with Christian S. Hendershot, PhD, and Klara R. Klein, MD, PhD, authors of Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial. Hosted by John Torous, MD.
Related Content: Once-Weekly Semaglutide in Adults With Alcohol Use Disorder Semaglutide Shows Promise in Reducing Alcohol Cravings
Predicting Adolescent Response to School-Based Mindfulness
18/02/2026 | 19 min
Interview with Christian A. Webb, PhD, author of Predicting Adolescent Response to School-Based Mindfulness: A Secondary Analysis of the MYRIAD Trial. Hosted by John Torous, MD.
Related Content: Predicting Adolescent Response to School-Based Mindfulness
Tailored Weight Loss Programs for Adults With Serious Mental Illness
17/12/2025 | 20 min
Interview with Amy N. Cohen, PhD, and Matthew Chinman, PhD, authors of Tailored Weight Loss Programs for Adults With Serious Mental Illness: A Randomized Clinical Trial. Hosted by John Torous, MD.
Related Content: Tailored Weight Loss Programs for Adults With Serious Mental Illness
Serial Ketamine Infusions as an Adjunctive Therapy to Inpatient Care for Depression
22/10/2025 | 22 min
Interview with Declan M. McLoughlin, PhD, author of Serial Ketamine Infusions as Adjunctive Therapy to Inpatient Care for Depression: The KARMA-Dep 2 Randomized Clinical Trial. Hosted by John Torous, MD.
Related Content: Serial Ketamine Infusions as Adjunctive Therapy to Inpatient Care for Depression
Interviews with authors of articles from JAMA Psychiatry. JAMA Psychiatry is an international peer-reviewed journal for clinicians, scholars, and research scientists in psychiatry, mental health, behavioral science, and allied fields. JAMA Psychiatry strives to publish original, state-of-the-art studies and commentaries of general interest to clinicians, scholars, and research scientists in the field. The journal seeks to inform and to educate its readers as well as to stimulate debate and further exploration into the nature, causes, treatment, and public health importance of mental illness.